Jack Youngren, Ph.D.

University of California, San Francisco
email: jfyphd@gmail.com

Grants

Potential New Drug Therapy for Breast Cancer 2002 (Cycle VIII)
STEP Award 8WB-0099 $199,740


Nordihydroguaiaretic Acid (NDGA) Inhibits the IGF-1 and c-erbB2/HER2/neu Receptors and Suppresses Growth in Breast Cancer Cells
  Periodical: Breast Cancer Research and Treatment
  Author(s): Youngren JF, Gable K, Penaranda C, Maddux BA, Zavodovskaya M, Lobo M, Campbell M, Kerner J
  Yr: 2005 Vol: 94 Nbr: 1 Pgs: 37-46
  Associated Grant: Potential New Drug Therapy for Breast Cancer